Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector.
Hematopoietic stem cell gene therapy requires the use of integrating retroviral vectors in order to stably transmit a therapeutic gene to mature blood cells. Human clinical trials have shown that some vector integration events lead to disrupted regulation of proto-oncogenes resulting in disordered h...
Main Authors: | Sheng Zhou, Zhijun Ma, Taihe Lu, Laura Janke, John T Gray, Brian P Sorrentino |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3633865?pdf=render |
Similar Items
-
Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair
by: Koldej Rachel M, et al.
Published: (2009-10-01) -
Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins
by: Seçkin Akgül, et al.
Published: (2022-02-01) -
Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01) -
Production of lentiviral vectors
by: Otto-Wilhelm Merten, et al.
Published: (2016-01-01) -
Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01)